GB1486557A - Process for the preparation of pyrogen-free sub-unit vaccine - Google Patents
Process for the preparation of pyrogen-free sub-unit vaccineInfo
- Publication number
- GB1486557A GB1486557A GB48685/73A GB4868573A GB1486557A GB 1486557 A GB1486557 A GB 1486557A GB 48685/73 A GB48685/73 A GB 48685/73A GB 4868573 A GB4868573 A GB 4868573A GB 1486557 A GB1486557 A GB 1486557A
- Authority
- GB
- United Kingdom
- Prior art keywords
- active agent
- density gradient
- pyrogen
- preparation
- free sub
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB48685/73A GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
ZA00746398A ZA746398B (en) | 1973-10-18 | 1974-10-08 | Preparation of vaccines |
SE7413113A SE426439B (sv) | 1973-10-18 | 1974-10-17 | Sett att framstella virusvaccin i vilket ingar fragment av eterkenligt virus |
DE2449530A DE2449530C2 (de) | 1973-10-18 | 1974-10-17 | Virusuntereinheitenimpfstoff |
AT835074A AT334524B (de) | 1973-10-18 | 1974-10-17 | Verfahren zur herstellung einer virus-untereinheiten-vaccine |
BE149618A BE821175A (fr) | 1973-10-18 | 1974-10-17 | Preparation de vaccins a fragments de virus apyretogenes |
NLAANVRAGE7413642,A NL181553C (nl) | 1973-10-18 | 1974-10-17 | Werkwijze voor de bereiding van een virus-subeenheid-vaccin. |
IL45870A IL45870A (en) | 1973-10-18 | 1974-10-17 | Process for preparation of vaccines |
CH1394974A CH611518A5 (en) | 1973-10-18 | 1974-10-17 | Process for the preparation of a virus subunit vaccine |
DK543974AA DK138581B (da) | 1973-10-18 | 1974-10-17 | Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus. |
NO743758A NO142024C (no) | 1973-10-18 | 1974-10-17 | Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus |
JP49119836A JPS5082228A (no) | 1973-10-18 | 1974-10-17 | |
CA211,654A CA1050886A (en) | 1973-10-18 | 1974-10-17 | Preparation of pyrogen free virus sub-unit vaccines |
AU74449/74A AU494738B2 (en) | 1974-10-18 | 1974-10-17 | Virus subunit vaccine |
IE2141/74A IE40187B1 (en) | 1973-10-18 | 1974-10-17 | Process for the preparation of pyrogen-free sub-unit vaccine |
FR7435179A FR2248054B1 (no) | 1973-10-18 | 1974-10-18 | |
US05/879,386 US4158054A (en) | 1973-10-18 | 1978-02-21 | Preparation of virus sub-unit vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB48685/73A GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1486557A true GB1486557A (en) | 1977-09-21 |
Family
ID=10449549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB48685/73A Expired GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5082228A (no) |
AT (1) | AT334524B (no) |
BE (1) | BE821175A (no) |
CA (1) | CA1050886A (no) |
CH (1) | CH611518A5 (no) |
DE (1) | DE2449530C2 (no) |
DK (1) | DK138581B (no) |
FR (1) | FR2248054B1 (no) |
GB (1) | GB1486557A (no) |
IE (1) | IE40187B1 (no) |
IL (1) | IL45870A (no) |
NL (1) | NL181553C (no) |
NO (1) | NO142024C (no) |
SE (1) | SE426439B (no) |
ZA (1) | ZA746398B (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002028426A1 (en) * | 2000-10-02 | 2002-04-11 | Glaxosmithkline Biologicals S.A. | Split enveloped virus preparation |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK276380A (da) * | 1979-07-09 | 1981-01-10 | Univ Iowa State Res Found Inc | Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis |
FR2470795A1 (fr) * | 1979-12-07 | 1981-06-12 | Pasteur Institut | Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus |
FR2475572A1 (fr) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
FR2483779A1 (fr) | 1980-06-05 | 1981-12-11 | Synthelabo | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3519400A (en) * | 1967-01-25 | 1970-07-07 | Atomic Energy Commission | Method of centrifugal separation and recovery of chemical species utilizing a liquid medium |
-
1973
- 1973-10-18 GB GB48685/73A patent/GB1486557A/en not_active Expired
-
1974
- 1974-10-08 ZA ZA00746398A patent/ZA746398B/xx unknown
- 1974-10-17 SE SE7413113A patent/SE426439B/xx unknown
- 1974-10-17 IL IL45870A patent/IL45870A/xx unknown
- 1974-10-17 IE IE2141/74A patent/IE40187B1/xx unknown
- 1974-10-17 AT AT835074A patent/AT334524B/de not_active IP Right Cessation
- 1974-10-17 CH CH1394974A patent/CH611518A5/xx not_active IP Right Cessation
- 1974-10-17 BE BE149618A patent/BE821175A/xx not_active IP Right Cessation
- 1974-10-17 NO NO743758A patent/NO142024C/no unknown
- 1974-10-17 DE DE2449530A patent/DE2449530C2/de not_active Expired
- 1974-10-17 NL NLAANVRAGE7413642,A patent/NL181553C/xx not_active IP Right Cessation
- 1974-10-17 CA CA211,654A patent/CA1050886A/en not_active Expired
- 1974-10-17 JP JP49119836A patent/JPS5082228A/ja active Pending
- 1974-10-17 DK DK543974AA patent/DK138581B/da not_active IP Right Cessation
- 1974-10-18 FR FR7435179A patent/FR2248054B1/fr not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002028426A1 (en) * | 2000-10-02 | 2002-04-11 | Glaxosmithkline Biologicals S.A. | Split enveloped virus preparation |
Also Published As
Publication number | Publication date |
---|---|
CH611518A5 (en) | 1979-06-15 |
DK138581B (da) | 1978-10-02 |
IL45870A (en) | 1978-03-10 |
IE40187B1 (en) | 1979-03-28 |
DE2449530A1 (de) | 1975-04-30 |
ATA835074A (de) | 1976-05-15 |
DE2449530C2 (de) | 1985-08-08 |
DK543974A (no) | 1975-06-16 |
NL7413642A (nl) | 1975-04-22 |
IL45870A0 (en) | 1974-12-31 |
NO743758L (no) | 1975-05-12 |
NO142024B (no) | 1980-03-10 |
NL181553C (nl) | 1987-09-16 |
FR2248054A1 (no) | 1975-05-16 |
NL181553B (nl) | 1987-04-16 |
SE7413113L (no) | 1975-04-21 |
ZA746398B (en) | 1976-06-30 |
AU7444974A (en) | 1976-04-29 |
JPS5082228A (no) | 1975-07-03 |
BE821175A (fr) | 1975-04-17 |
IE40187L (en) | 1975-04-18 |
DK138581C (no) | 1979-03-12 |
FR2248054B1 (no) | 1978-07-28 |
AT334524B (de) | 1976-01-25 |
SE426439B (sv) | 1983-01-24 |
NO142024C (no) | 1980-06-18 |
CA1050886A (en) | 1979-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9102976L (sv) | Hybrid dna vektorer, encelliga organismer och bakterier till anvaendning foer produktion av hiv-proteiner och peptider | |
OA04704A (fr) | Procédé de préparation de nouveaux vaccins. | |
SE409216B (sv) | Forfarande for framstellning av papper, som innehaller plast vilken till overvegande del er uppbyggd av estrar av akryl- och/eller metakrylsyra och/eller styren | |
FI905184A0 (fi) | Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3. | |
ATA852374A (de) | Verfahren zur herstellung von neuen 1,2-benzisoxazol-derivaten | |
GB1486557A (en) | Process for the preparation of pyrogen-free sub-unit vaccine | |
DK160274C (da) | Fremgangsmaade til fremstilling af 4'-deoxydaunorubicin eller 4'-deoxydoxorubicin | |
ES8104405A1 (es) | Procedimiento para preparar una vacuna de virus de gripe | |
GB1292803A (en) | Improvements relating to the production of antigens | |
ES432385A1 (es) | Un metodo de obtener una cepa de virus de la gripe. | |
ES427548A1 (es) | Procedimiento para la preparacion de 2,2,6,6-tetrametil-4- oxopiperidina. | |
GB2001326A (en) | Glycoproteins from paramyxovirus and vaccines therefrom | |
DK115349B (da) | Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni. | |
DE2966807D1 (en) | Process for the preparation of unsaturated mono-ethers of diphenols | |
CH557413A (de) | Verfahren zur herstellung hochkonzentrierter farbstoffund pigmentpraeparate. | |
CH426067A (de) | Verfahren zur Herstellung unsymmetrischer 4-Halogen-4',4''-diarylamino-triphenylmethan-Farbstoffe | |
GB1016586A (en) | Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis | |
GB958574A (en) | Clostridium perfringens ª‰-toxoid vaccines | |
GB1039722A (en) | Process for the manufacture of a foot-and-mouth disease vaccine containing a live virus | |
FR2290220A2 (fr) | Nouveau vaccin antirabique | |
SE7910489A (sv) | Isoindolinforeningar och forfarande for framstellning derav | |
BE797468A (en) | Pasteurella antigens and vaccines - antipasteurellosis in mammalian animals and birds | |
GB770852A (en) | Vaccine products and process of producing the same | |
Robertson et al. | CHANGES IN THE HAEMAGGLUTININ OF INFLUFNZA VIRUS DURING EGG ADAPTATION | |
DK90128C (da) | Fremgangsmåde til fremstilling af en vandig vævskulturvæske, indeholdende en høj koncentration af levende >>smitsom hepatitis<<-virus. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19941016 |